Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Julie A. Sosa, MD, FACS
Yale University School of Medicine, New Haven, CT
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
41 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Belarus National Medical University
Minsk, Belarus
- Regional Oncology Dispensary With Inpatient Sector
Plodiv, Bulgaria
- Specialized Hospital for Active Treatment of Oncology
Sofia, Bulgaria
- Universtiy Multiprofile Hospital, Isui, Clinic of Oncotherapy
Sofia, Bulgaria
- University Hospital, Cairo
Cairo, Egypt
- Mediciti Hospital
Hyderabaad, Andhra Pradesh, India
- Kidwai Memorial Hospital
Bangalore, Karnataka, India
- Shirdi Sai Baba Cancer Hospital
Manipal, Karnataka, India
- Tata Memorial Centre
Mumbai, Maharashtra, India
- Ruby Hall Clinic
Pune, Maharashtra, India
- All India Institute of Medical Sciences
New Delhi, National Capital Territory of Delhi, India
- Apollo Cancer Institute
New Delhi, National Capital Territory of Delhi, India
- Christian Medial College
Vellore, Tamil Nadu, India
- Telaviv Sourasky Medical Center, Head and Neck Service Division of Oncology
Tel Aviv, Israel
- Lo Studio E la Cura
Milan, Italy
- Int Napoli Fondazione Pascale
Naples, Italy
- Istituto Oncologico Veneto (iov) - Irccs
Padova, Italy
- Azienda Ospedaliero - Universitaria Pisana
Pisa, Italy
- Zaklad Medyczny Nuklearnej I Endykrynologii
Gliwice, Poland
- Klinika Nowotworow Glowy I Szyji
Warsaw, Poland
- Institutul Oncologic
Cluj-Napoca, Romania
- Sc Meditech Srl
Craiova, Romania
- Centr of Medical Oncology
Iași, Romania
- Clinical County Hospital Sibiu
Sibiu, Romania
- Emergency Clinical County Hospital "sf. Loan Cel Nou"
Suceava, Romania
- City Clinical Oncology Dispensary
Saint Petersburg, Russia
- Ukrainian Academy of Medical Science
Lomonosova 33/43, Kiev, Ukraine
- Regional Clinical Oncology Dispensary
Lviv, Ukraine
- Beatson Oncology Centre, Gartnavel General Hospital
Glasgow, Scotland, United Kingdom
- Royal Marsden Hospital and Institute of Cancer Research
London, United Kingdom
- Southampton Hospital Oncology Centre
Southampton, United Kingdom
- Usc/norris Comprehensive Cancer Center
Los Angeles, California, United States
- University of Colorado Cancer Center
Aurora, Colorado, United States
- Yale University, School of Medicine
New Haven, Connecticut, United States
- Winship Cancer Institute, Emory University
Atlanta, Georgia, United States
- Sidney Kimmel Comprehensive Cancer Care Center at John Hopkins
Baltimore, Maryland, United States
- University of Minnesota Otolaryngology Department
Minneapolis, Minnesota, United States
- Ireland Cancer Center/division Od Hematology
Cleveland, Ohio, United States
- Oregon Health and Science University
Portland, Oregon, United States
- University of Texas M.D. Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2007
- Primary completion
- 31 Oct 2011
- Completion
- 30 Nov 2011
- Last update posted
- 9 Jun 2014
- Registered enrollment
- 80
- Registry id
- NCT00507429
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.